DE NICOLAO, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 11.818
AS - Asia 8.728
EU - Europa 7.592
SA - Sud America 931
AF - Africa 251
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 15
AN - Antartide 1
Totale 29.352
Nazione #
US - Stati Uniti d'America 11.570
CN - Cina 4.567
SG - Singapore 1.947
IE - Irlanda 1.549
UA - Ucraina 1.133
HK - Hong Kong 872
DE - Germania 796
FI - Finlandia 755
RU - Federazione Russa 713
BR - Brasile 672
VN - Vietnam 583
NL - Olanda 522
SE - Svezia 485
FR - Francia 457
GB - Regno Unito 456
IT - Italia 451
IN - India 178
CA - Canada 126
ZA - Sudafrica 123
BD - Bangladesh 86
AR - Argentina 82
IQ - Iraq 78
MX - Messico 75
BE - Belgio 53
PL - Polonia 50
TR - Turchia 49
JP - Giappone 45
CO - Colombia 41
EC - Ecuador 41
PK - Pakistan 41
MA - Marocco 34
ES - Italia 33
MY - Malesia 29
ID - Indonesia 28
UZ - Uzbekistan 28
VE - Venezuela 28
AT - Austria 27
PH - Filippine 23
PT - Portogallo 23
SA - Arabia Saudita 22
CL - Cile 21
AZ - Azerbaigian 18
JO - Giordania 18
PY - Paraguay 16
LT - Lituania 15
EU - Europa 14
TN - Tunisia 14
AU - Australia 13
IR - Iran 13
BO - Bolivia 12
AE - Emirati Arabi Uniti 11
DZ - Algeria 11
EG - Egitto 11
PE - Perù 11
SK - Slovacchia (Repubblica Slovacca) 11
NP - Nepal 10
KE - Kenya 9
KG - Kirghizistan 9
CZ - Repubblica Ceca 8
ET - Etiopia 8
KR - Corea 8
TH - Thailandia 8
BH - Bahrain 7
CH - Svizzera 7
DO - Repubblica Dominicana 7
JM - Giamaica 7
KZ - Kazakistan 7
OM - Oman 7
PA - Panama 7
BY - Bielorussia 6
GR - Grecia 6
HN - Honduras 6
KW - Kuwait 6
NG - Nigeria 6
NO - Norvegia 6
SN - Senegal 6
AL - Albania 5
LV - Lettonia 5
LY - Libia 5
PS - Palestinian Territory 5
TW - Taiwan 5
UY - Uruguay 5
IL - Israele 4
RO - Romania 4
TT - Trinidad e Tobago 4
CR - Costa Rica 3
GA - Gabon 3
GE - Georgia 3
GT - Guatemala 3
HU - Ungheria 3
LB - Libano 3
NI - Nicaragua 3
RS - Serbia 3
SV - El Salvador 3
CI - Costa d'Avorio 2
DK - Danimarca 2
LK - Sri Lanka 2
MU - Mauritius 2
PR - Porto Rico 2
SO - Somalia 2
Totale 29.312
Città #
Chandler 1.580
Dublin 1.548
Jacksonville 1.338
San Jose 1.131
Nanjing 1.099
Singapore 999
Ashburn 920
Hong Kong 836
Dallas 693
Boardman 645
Beijing 636
Nanchang 423
Princeton 327
Shenyang 306
Lawrence 296
Wilmington 289
Hebei 285
Lauterbourg 282
Los Angeles 276
Changsha 266
Jiaxing 255
Ann Arbor 236
Medford 219
Ho Chi Minh City 210
Helsinki 169
Tianjin 155
Buffalo 152
Council Bluffs 151
Hangzhou 151
Milan 137
Hanoi 129
Moscow 129
Woodbridge 119
Shanghai 116
New York 106
Piscataway 106
Johannesburg 97
Munich 95
Redondo Beach 88
Dearborn 81
Santa Clara 70
Verona 65
São Paulo 62
Orem 61
Norwalk 59
Seattle 53
Chicago 49
Brussels 48
Toronto 47
Frankfurt am Main 46
Pavia 46
The Dalles 45
Houston 43
Guangzhou 38
Tokyo 37
Turku 37
Warsaw 37
Des Moines 36
Kunming 34
Montreal 33
Falkenstein 32
London 30
Zhengzhou 30
Jinan 29
Mexico City 29
San Francisco 29
Brooklyn 27
Fairfield 25
Tashkent 25
Baghdad 23
Chennai 23
Da Nang 23
Dong Ket 23
Ningbo 23
Stockholm 23
Amsterdam 22
Boston 22
Manchester 22
Poplar 22
Rio de Janeiro 22
Atlanta 21
Denver 21
Nuremberg 20
Rome 20
Salvador 20
Washington 20
Mumbai 19
Amman 18
Hải Dương 17
Pune 17
Haiphong 16
Phoenix 16
Auburn Hills 15
Dhaka 15
Guayaquil 15
Kuala Lumpur 15
Quito 15
Taizhou 15
Baku 14
Buenos Aires 14
Totale 18.869
Nome #
Steady-state equivalence of drug- and biomarker driven models in tumor growth experiments 591
First-order longitudinal population model of FEV1 data: single-trial modeling and meta-analysis 180
Tumor-growth inhibition in preclinical animal studies: steady-state analysis of biomarker-driven models 176
A Bayesian approach to non-parametric AUC estimation in population studies 166
Artificial pancreas: Model predictive control design from clinical experience 161
Biomarker-driven models of tumor growth inhibition in preclinical animal studies 152
MPC-based artificial pancreas: Strategies for individualization and meal compensation 152
A stabilizing model-based predictive control for nonlinear systems 151
A PK-PD model of tumor growth after administration of an anti-angiogenic agent given alone or in combination therapies in xenograft mice 143
Population Pharmacokinetic Model of Ibrutinib, a BTK Inhibitor for the Treatment of B-cell malignancies 141
A Target-Mediated Drug Disposition model integrated with a T lymphocyte pharmacodynamic model for Otelixizumab. 139
A Bayesian nonparametric approach to AUC determination in population studies 137
A mathematical model to study the effects of drugs administration on tumor growth dynamics 137
In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment time 135
A Target-Mediated Drug Disposition model to quantify the relationship between Otelixizumab in vitro concentration and TCR/CD3 engagement 135
PCA-based modelling in antidepressant trials: a pre-mechanistic approach 135
Multistep virtual metrology approaches for semiconductor manufacturing processes 135
A PCA approach to population analysis: with application to a Phase II depression trial 134
Methods and tools for multiscale modelling in Systems Pharmacology: a review 133
Continuous-time Markov modelling of flexible-dose depression trials 132
Bayesian population approaches to the analysis of dose escalation studies 132
A Kalman filtering algorithm for regularization networks 132
Multilevel Lasso Applied to Virtual Metrology in Semiconductor Manufacturing 130
Counting events: population approaches using NONMEM 129
Adaptive Controllers for Intelligent Monitoring 129
Integration of response, tolerability and dropout in flexible-dose trials: a case study in depression 129
A Target-Mediated Drug Disposition model to quantify the relationship between Anti-CD3 monoclonal antibody and CD3/TCR receptors in Patients with autoimmune diseases. 128
A Minimal Model of Tumor Growth Inhibition in Combination Regimens under the Hypothesis of no Interaction between Drugs 126
Multi-step virtual metrology for semiconductor manufacturing: A multilevel and regularization methods-based approach 126
A nonparametric approach for model individualization in an artificial pancreas 125
Model predictive control: output feedback and tracking of nonlinear systems 124
Heart rate correction of the QT interval: a nonparametric individualized approach 124
Modeling myelosuppression in patients treated with anticancer drugs 124
Predicting the active doses in humans from animal studies: A novel approach in oncology 123
Some comments on nu-Support Vector Machines 122
Fully Integrated Artificial Pancreas in Type 1 Diabetes: Modular Closed-Loop Glucose Control Maintains Near Normoglycemia 122
Second-order indirect response modelling of complex biomarker dynamics 122
A hidden-Gamma model-based filtering and prediction approach for monotonic health factors in manufacturing 122
Fast calibration of two-factor models for energy option pricing 122
Process Diagnosis via Electrical-Wafer-Sorting Maps Classification 120
ACID: Automatic classification of sort test maps for interactive process diagnosis 120
Particle filtering of hidden Gamma processes for robust Predictive Maintenance in semiconductor manufacturing 120
An information-theory and Virtual Metrology-based approach to Run-to-Run semiconductor manufacturing control 120
Second order Markov modelling of HAMD responses in depression trials 120
Identification and idle speed control of internal combustion engines 119
Population pharmacokinetic model of ibrutinib, a Bruton tyrosine kinase inhibitor, in patients with B cell malignancies 119
Population state-space modelling of patient responses in antidepressant studies 118
Tumor growth modelling for drug development 117
Evaluation of software tools for Bayesian estimation on population models with count and continuous data 117
Evaluation of software tools for Bayesian estimation on population models:an update based on current software versions 117
Multilevel Lasso Applied to Virtual Metrology in Semiconductor Manufacturing 116
A new kernel-based approach for linear system identification 115
A state-space approach to disease and dropout modelling in Phase II clinical trials 115
Proportional Hazard Model with L1 Penalization applied to Predictive Maintenance in Semiconductor Manufacturing 115
Kernel methods in system identification, machine learning and function estimation: A survey 115
Model Predictive Control of Type 1 diabetes added to conventional therapy 115
A PK-PD model for predicting tumor growth inhibition in mice: a useful tool in oncology drug development 115
A collision risk assessment approach as a basis for the on-board warning generation in cars 115
Multilevel kernel methods for virtual metrology in semiconductor manufacturing 114
Nonparametric identification of pharmacokinetic population models via Gaussian processes 113
Nonparametric identification of population models via Gaussian processes 113
A mininal model of tumor growth inhibition 113
Testing additivity of anticancer agents in pre-clinical studies: A PK/PD modelling approach 113
H-infinity differential Riccati equations: convergence properties and finite escape phenomena 112
Disease and dropout modelling in depression trials: a state-space approach 112
AC/ID: a Wafer Oriented Process Diagnosis Techniques 112
Temporal pharmacokinetic/pharmacodynamic interaction between human CD3ε antigen-targeted monoclonal antibody otelixizumab and CD3ε binding and expression in human peripheral blood mononuclear cell static culture 112
MPC based Artificial Pancreas: Strategies for individualization and meal compensation 112
Multilevel statistical process control of asynchronous multi-stream processes in semiconductor manufacturing 112
Population modeling of tumor growth inhibition in vivo: application to anticancer drug development 111
H_infinity-robustness of adaptive filters against measurement noise and parameter drift 111
A New Neural Network Approach for Short-Term Glucose Prediction Using Continuous Glucose Monitoring Time-Series and Meal Information 111
An Algebraic Characterization of the Optimum of Regularized Kernel Methods 111
Nonparametric modelling of in vitro antitumor pharmacodynamic studies to optimize drug concentration and treatment time 110
Bayesian online multi-task learning of Gaussian processes 110
A new kernel-based approach for system identification 110
MPBPK-TMDD models for mAbs: alternative models, comparison, and identifiability issues 110
A model based approach to the in vitro evaluation of anticancer activity 109
A new, second-order indirect model of depression time course 109
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 109
A Novel Nonparametric Approach for the Identification of the Glucose-Insulin System in Type 1 Diabetic Patients 109
A new statistical algorithmm to enhance volume diagnostic effectiveness and accuracy 108
Dose escalation studies in Phase I clinical trials: a comparison among Bayesian population approaches 108
Population modeling of tumor growth in untreated xenografted mice 107
PK/PD modeling of tumor growth inhibition in vivo 107
Method to evaluate the systemic exposure in toxicological and pharmacological studies 107
A multi-task learning approach for the extraction of single-trial evoked potentials 107
Current mathematical models for cancer drug discovery 107
Nonparametric input estimation in physiological systems: Problems, methods, case studies 106
Modelling of the outcome of non-inferiority trials by integration of historical data 106
An EKF-based algorithm for automatic tuning and control of electrical drives 106
Model predictive control of type 1 diabetes: An in silico trial 106
A letter on Ancaiani et al. ‘Evaluating scientific research in Italy: the 2004-10 research evaluation exercise’ 106
Dose escalation studies: a comparison among Bayesian models 105
Re: Antitumor Efficacy Testing in Rodents 105
Modeling of human tumor xenografts and dose rationale in oncology 105
A minimal model describing the effect of drug administration on tumor growth dynamics 105
Multilevel Lasso Applied to Virtual Metrology in Semiconductor Manufacturing 105
Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth kinetics in xenograft models after administrations of anticancer agents 105
On the zeros of discrete-time linear periodic systems 104
Totale 12.557
Categoria #
all - tutte 121.647
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.647


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202199 0 0 0 0 0 0 0 0 0 0 0 99
2021/20221.721 20 11 39 20 17 39 22 81 66 29 221 1.156
2022/20234.519 496 310 66 350 543 435 8 238 1.858 31 130 54
2023/20241.537 179 231 75 111 152 328 57 133 13 45 138 75
2024/20253.995 92 401 81 173 131 138 137 373 968 92 436 973
2025/20269.070 700 604 1.031 796 1.146 408 1.782 331 760 813 376 323
Totale 29.533